Biomarin Pharmaceutical Inc (BMRN) Insider Trading
- $1,316,196.75
- $342,139,664.94
- Nov. 12, 2024
- Jean Jacques Bienaime
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 27, 2016 | Director | 1,100 | $95.39 | Sell | $104,929.00 | |
July 22, 2016 | Director | 6,400 | $95.01 | Sell | $608,064.00 | |
July 18, 2016 | CEO | 41,666 | $92.72 | Sell | $3,863,271.52 | |
July 7, 2016 | EVP | 2,167 | $90.00 | Sell | $195,030.00 | |
June 20, 2016 | Director | 550 | $82.77 | Sell | $45,523.50 | |
June 16, 2016 | CEO | 41,666 | $80.55 | Sell | $3,356,196.30 | |
June 6, 2016 | CFO | 1,649 | $89.14 | Sell | $146,991.86 | |
May 31, 2016 | CFO | 20,841 | $89.88 | Sell | $1,873,189.08 | |
May 26, 2016 | EVP | 15,000 | $87.81 | Sell | $1,317,150.00 | |
May 23, 2016 | CFO | 3,769 | $87.07 | Sell | $328,166.83 | |
May 18, 2016 | EVP | 5,000 | $87.05 | Sell | $435,250.00 | |
May 10, 2016 | EVP | 14,658 | $85.11 | Sell | $1,247,542.38 | |
May 5, 2016 | CEO | 50,000 | $80.15 | Sell | $4,007,500.00 | |
May 3, 2016 | EVP | 415 | $86.03 | Sell | $35,702.45 | |
May 2, 2016 | CEO | 36,500 | $85.01 | Sell | $3,102,865.00 | |
March 14, 2016 | EVP | 1,996 | $86.21 | Sell | $172,075.16 | |
March 4, 2016 | SVP | 1,255 | $88.42 | Sell | $110,967.10 | |
March 2, 2016 | CFO | 4,623 | $86.12 | Sell | $398,132.76 | |
March 1, 2016 | CEO | 10,000 | $84.28 | Sell | $842,800.00 | |
Feb. 22, 2016 | Director | 7,500 | $80.00 | Sell | $600,000.00 | |
Dec. 16, 2015 | SVP | 1,362 | $100.00 | Sell | $136,200.00 | |
Nov. 30, 2015 | CEO | 1,000 | $94.74 | Sell | $94,740.00 | |
Nov. 16, 2015 | Director | 8,550 | $106.90 | Sell | $913,995.00 | |
Nov. 16, 2015 | CFO | 20,000 | $104.30 | Sell | $2,086,000.00 | |
Oct. 15, 2015 | CEO | 1,000 | $108.24 | Sell | $108,240.00 | |
Sept. 14, 2015 | CEO | 1,000 | $131.43 | Sell | $131,430.00 | |
July 20, 2015 | SVP | 3,000 | $150.00 | Sell | $450,000.00 | |
July 7, 2015 | CEO | 1,500 | $139.07 | Sell | $208,605.00 | |
June 5, 2015 | EVP | 1,864 | $122.32 | Sell | $228,004.48 | |
June 5, 2015 | CFO | 1,649 | $122.30 | Sell | $201,672.70 | |
June 4, 2015 | SVP | 1,362 | $122.35 | Sell | $166,640.70 | |
June 1, 2015 | SVP | 377 | $123.76 | Sell | $46,657.52 | |
June 1, 2015 | CFO | 5,523 | $124.73 | Sell | $688,883.79 | |
May 29, 2015 | CFO | 1,578 | $126.15 | Sell | $199,064.70 | |
May 26, 2015 | SVP | 1,625 | $126.55 | Sell | $205,643.75 | |
May 18, 2015 | CFO | 2,059 | $124.77 | Sell | $256,901.43 | |
May 18, 2015 | SVP | 2,558 | $125.26 | Sell | $320,415.08 | |
May 18, 2015 | EVP | 1,864 | $124.78 | Sell | $232,589.92 | |
May 13, 2015 | EVP | 1,434 | $121.37 | Sell | $174,044.58 | |
May 11, 2015 | EVP | 2,869 | $121.64 | Sell | $348,985.16 | |
March 17, 2015 | CEO | 2,000 | $124.17 | Sell | $248,340.00 | |
March 16, 2015 | EVP | 41,315 | $123.57 | Sell | $5,105,294.55 | |
March 16, 2015 | CEO | 1,000 | $123.48 | Sell | $123,480.00 | |
March 10, 2015 | CEO | 21,021 | $112.39 | Sell | $2,362,550.19 | |
March 9, 2015 | CEO | 19,000 | $112.13 | Sell | $2,130,470.00 | |
March 5, 2015 | EVP | 14,051 | $116.37 | Sell | $1,635,114.87 | |
March 5, 2015 | CEO | 10,000 | $113.70 | Sell | $1,137,000.00 | |
March 4, 2015 | CEO | 13,916 | $107.92 | Sell | $1,501,814.72 | |
March 3, 2015 | CEO | 5,000 | $107.42 | Sell | $537,100.00 | |
March 2, 2015 | CFO | 15,500 | $107.00 | Sell | $1,658,500.00 |
Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.
The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere
The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.
Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.
David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.
The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.
The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.
The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.